Dr. F. Anto Nazarene, et al. “NEUROPHYSIOLOGICAL CHANGES AND SERUM ANTINUCLEAR ANTIBODY LEVELS IN DEMENTIA AND HIGH-RISK GROUPS”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 32, no. 10, Dec. 2025, pp. 1801-13, https://doi.org/10.53555/j96gax27.